Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma
Cancer Cell · 2026-11
DOI: 10.1016/j.ccell.2026.10.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2026-11. Verfasst von Julia Schiantarelli und 14 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Schiantarelli, J., Benamar, M., Park, J., Sax, H. E., Oliveira, G., Bosma-Moody, A., Campbell, K. M., Liu, D., Johnson, D. B., Rodig, S., Wu, C. J., Hodi, F. S., Ribas, A., Allen, E. V., & Haq, R. (2026). Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.10.011
Vancouver
Schiantarelli J, Benamar M, Park J, Sax HE, Oliveira G, Bosma-Moody A, et al. Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma. Cancer Cell. 2026. doi:10.1016/j.ccell.2026.10.011
BibTeX
@article{Schiantarelli2026,
author = {Schiantarelli, Julia and Benamar, Mouadh and Park, Jihye and Sax, Haley E. and Oliveira, Giacomo and Bosma-Moody, Alice and Campbell, Katie M. and Liu, David and Johnson, Douglas B. and Rodig, Scott and Wu, Catherine J. and Hodi, F. Stephen and Ribas, Antoni and Allen, Eliezer Van and Haq, Rizwan},
title = {Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma},
journal = {Cancer Cell},
year = {2026},
doi = {10.1016/j.ccell.2026.10.011}
}
EUVIMED